Pacer Advisors’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$658K Buy
2,547
+835
+49% +$222K ﹤0.01% 1384
2025
Q4
$422K Buy
1,712
+1,105
+182% +$233K ﹤0.01% 1828
2025
Q3
$107K Buy
607
+152
+33% +$22.8K ﹤0.01% 2249
2025
Q2
$62.5K Sell
455
-253
-36% -$37.2K ﹤0.01% 2895
2025
Q1
$128K Sell
708
-692
-49% -$116K ﹤0.01% 1923
2024
Q4
$219K Buy
+1,400
New +$248K ﹤0.01% 1904
2024
Q3
Sell
-238
Closed -$43.7K 2630
2024
Q2
$43.7K Sell
238
-14
-6% -$2.35K ﹤0.01% 3238
2024
Q1
$44.8K Buy
+252
New +$35K ﹤0.01% 3211
2021
Q2
Sell
-602
Closed -$46K 1486
2021
Q1
$46K Sell
602
-6
-1% -$436 ﹤0.01% 1447
2020
Q4
$36K Sell
608
-240
-28% -$12K ﹤0.01% 1444
2020
Q3
$37K Buy
+848
New +$36.8K ﹤0.01% 1317

Other funds holding KRYS